FDA Adverse Event Injury Summary report: N

EVOLUT R TRANSCATHETER AORTIC VALVE

MDR report key: 6771017 · Received August 7, 2017

Report

Report Number
2025587-2017-01315
Event Type
Injury
Date Received
August 7, 2017
Date of Event
March 23, 2017
Report Date
July 14, 2017
Manufacturer
MEDTRONIC HEART VALVES DIVISION
Product Code
NPT
PMA / PMN Number
P130021
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

CITATION: Y. MAENO ET AL. "TRANSCATHETER AORTIC VALVE REPLACEMENT WITH DIFFERENT VALVE TYPES IN ELLIPTIC AORTIC ANNULI" CIRCULATION JOURNAL 2017; 81: 1036¿1042. DOI: 10.1253/CIRCJ.CJ-16-1240 EARLIEST DATE OF PUBLISH USED FOR EVENT DATE. NO UNIQUE DEVICE IDENTIFIER (SERIAL/LOT) NUMBERS WERE PROVIDED; WITHOUT THIS INFORMATION IT COULD NOT BE DETERMINED WHETHER THESE OBSERVATIONS HAVE BEEN PREVIOUSLY REPORTED. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFORMATION VIA LITERATURE REGARDING TRANSCATHETER AORTIC VALVE REPLACEMENT WITH DIFFERENT VALVE TYPES IN ELLIPTIC AORTIC ANNULI. ALL DATA WERE COLLECTED FROM A SINGLE CENTER BETWEEN 2013 AND JANUARY 2016. THE STUDY POPULATION INCLUDED 737 PATIENTS (PREDOMINANTLY MALE, MEAN AGE 83 YEARS), 120 OF WHICH WERE IMPLANTED WITH MEDTRONIC COREVALVE, AND EVOLUTR (SERIAL NUMBERS NOT PROVIDED). AMONG ALL PATIENTS ADVERSE EVENTS INCLUDED: MILD PARAVALVULAR LEAK (PVL), MODERATE-SEVERE PVL REQUIRING SECOND VALVE IMPLANT, INCREASED GRADIENT, LESS EFFECTIVE ORIFICE AREA, IMPROPER SIZING, VALVE EMBOLIZATION, PACEMAKER IMPLANT NEEDED, AND MYOCARDIAL INFARCTION. BASED ON THE AVAILABLE INFORMATION, THESE ADVERSE EVENTS MAY HAVE BEEN ATTRIBUTED TO MEDTRONIC PRODUCT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
552332 EVOLUT R TRANSCATHETER AORTIC VALVE AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED NPT MEDTRONIC HEART VALVES DIVISION EVOLUTR-29

Patients

Seq Age Sex Outcome Treatment
1 83 YR Required Intervention